ArticleBioinformatics advances2026
DeepBCTPred: deep learning-based prediction of bladder cancer tissues from endoscopic images.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Bladder cancer is one of the most prevalent malignancies worldwide, affecting the tissues of the urinary bladder and posing a significant threat to patient survival and quality of life. Accurate classification of bladder cancer tissue is critical for early diagnosis and patient survival, yet conventional methods suffer from subjective interpretation and human error. Results: We propose DeepBCTPred, a novel deep learning framework that integrates handcrafted and learned features through a dual-branch architecture combining MobileNetV3 with a Feedforward Neural Network. Our approach incorporates Recursive Feature Elimination (RFE) for feature selection and employs a genetic algorithm-based image generation pipeline for optimal data selection. DeepBCTPred achieved superior performance with 98.74% recall, 99.45% specificity, and 97.96% F1-score on the test dataset, significantly outperforming existing state-of-the-art methods, achieving improvements ranging from 2% to 15% in recall, 1.3%-13.1% in F1-score, and 1.5%-16% in Matthews Correlation Coefficient (MCC). This framework demonstrates strong potential for clinical implementation in bladder cancer diagnosis and may be extensible to other cancer types for enhanced precision medicine applications. Availability and implementation: The training, validation, and test scripts are freely available at https://github.com/nafcoder/DeepBCTPred.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.